Inpatient and Outpatient Orderable

Adalimumab and Anti-Adalimumab Antibody (DoseAssure) Build info

Synonyms

  • ADALIMUMAB LEVEL AND ANTIBODY
  • ADALIMAMAB
  • ADALIMAUMAB AB
  • LAB10041

Procedure Name

ADALIMUMAB LEVEL AND ANTIBODY

Procedure Master Number

LAB10041

Procedure ID

169902

Clinical Info

Monitor antiadalimumab therapy for individuals with Crohn's disease, inflammatory bowel disease, ulcerative colitis, rheumatoid arthritis, or other autoimmune conditions. This test provides adalimumab drug concentration levels as well as the level of antiadalimumab antibodies.

Specimen Sources

 Blood, Arterial Blood, Capillary Blood, Central Line Blood, Venous

Specimen Types

 Blood

Container

Gold Top Tube

Collection Instructions

Container/Tube: Red top or Gold top tube
Specimen: 2ml serum (1 mL min)
Transport Temperature: Frozen

Specimen Volume

2 mL serum (1 mL min)

Transport Instructions

Frozen

Specimen Stability

7 Days Room Temperature
7 Days Refrigerated
308 Days Frozen

Methodology

Electrochemiluminescence immunoassay (ECLIA)

Days Performed

TAT: 7-10 Days

Performing Laboratory

LabCorp of America

CPT

80145
82397
LOINC Code: 99781-7

PDM

 5903888

Only Orderable at Locations:

 Orderable Everywhere

Results
Component Name Base Name Common Name External Name
ADALIMUMAB DRUG LEVEL ADALIMDRUG ADALIMUMAB DRUG LEVEL Adalimumab Drug Level
ANTI-ADALIMUMAB ANTIBODY AADALIMUMAB ANTI ADALIMUMAB AN Anti-Adalimumab Antibody

Result Interpretation

Adalimumab Drug Level
• Quantitation limit: <0.6 μg/mL

• Results ≥0.6 μg/mL indicate detection of adalimumab.

In the presence of antiadalimumab antibody, the adalimumab drug level reflects the antibody-unbound fraction of adalimumab concentration in serum.
Antiadalimumab Antibody
 
• Quantitation limit: <25 ng/mL

• Results ≥25 ng/mL indicate detection of adalimumab antibody.

Forms
edit